Table 1.

AS p53 Oligonucleotide–Induced Modification of Expression of Apoptosis-Related Genes

Activated GeneFold Change (AS*/control)Repressed GeneFold Change (AS/control)
SERPINB29.7805TNFSF10−9.4317
SPATA34.4796TP53−9.063
SPHK14.1911DAPK1−6.1304
PPP1R15A3.7702TNFRSF1A−5.5697
THAP13.4045BNIP3−5.1213
IL63.2589TNFRSF9−5.0876
BAG13.1076SCARB1−4.8935
FLJ396163.0146GFRA1−4.1561
MOAP12.9053STK25−3.3605
TNFRSF10D2.8171FXR2−3.1267
KIRREL22.4332BNIP3L−3.0589
MST42.2512STAT6−3.0511
CARD62.2496MAGED1−2.9045
SGKL2.2042AVEN−2.6139
BCL2L112.1961DAP−2.5864
WWOX2.1883STAT5B−2.5504
GADD45A2.1771ARHGEF1−2.5022
GFRA32.1092NALP1−2.4995
BCL2A12.1031PDCD6−2.357
HSPC1592.0089STAT3−2.342
TRADD−2.3269
CAMKK2−2.3087
BCL2L1−2.2924
MLLT7−2.2343
CLU−2.2199
RAI−2.1889
MAGED2−2.1317
TRAF5−2.117
C20orf158;DATF1−2.1089
BOK−2.0966
MGC4171;MAPK3−2.0909
SCARB2−2.0811
APG5L−2.0409
  • *AS, p53-specific AS oligonucleotide treatment.